Compounds > plerixafor

Page last updated: 2024-08-24

plerixafor and HIV

plerixafor has been researched along with HIV in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (21.43)	18.2507
2000's	6 (42.86)	29.6817
2010's	4 (28.57)	24.3611
2020's	1 (7.14)	2.80

Authors

Authors	Studies
Asaftei, S; De Clercq, E	1
Bachan, S; Fantini, J; Garg, H; Joshi, A; Mootoo, DR	1
Huang, B; Kang, D; Liu, N; Liu, X; Zhan, P; Zhang, H; Zhao, F	1
Fujino, M; Kaneko, M; Kobayakawa, T; Murakami, T; Owusu, KB; Tamamura, H; Tsuji, K; Wang, R; Yamamoto, N	1
De Clercq, E	1
Borrell, JI; Clotet, B; Esté, JA; Mena, MP; Pérez-Nueno, VI; Pettersson, S; Teixidó, J	1
Blauvelt, A; Borris, DL; Gulden, FO; Kawamura, T; Lederman, MM; McNamara, DT; Orenstein, JM; Sugaya, M; Zimmerman, PA	1
Akashi, H; Haining, H; Hosie, MJ; Ikeda, Y; McMonagle, EL; Miyazawa, T; Shimojima, M; Takeuchi, Y; Willett, BJ	1
Balzarini, J; Böhlmstedt, A; Bölmstedt, A; De Clercq, E; Hatse, S; Peumans, W; Schols, D; Van Damme, E; Van Laethem, K; Vandamme, AM; Vermeire, K	1
Armand-Ugón, M; Ballana, E; Clotet, B; Clotet-Codina, I; De Marco, S; Esté, JA; Gombert, FO; Llano, A; Moncunill, G; Pauls, E; Romagnoli, B; Vrijbloed, JW	1
De Clercq, E; Esté, JA; Henson, G; Schols, D	1
De Clercq, E; Esté, JA; Henson, G; Schols, D; Struyf, S; Van Damme, J	1
Schols, D	1
Bolognesi, DP; Galasso, G; Hammer, SM; Hirsch, MS; LaBranche, CC; Moore, JP	1

Reviews

3 review(s) available for plerixafor and HIV

Article	Year
Discovery of non-peptide small molecular CXCR4 antagonists as anti-HIV agents: Recent advances and future opportunities. European journal of medicinal chemistry, 2016, May-23, Volume: 114 Topics: Anti-HIV Agents; Drug Discovery; HIV; Humans; Microbial Sensitivity Tests; Molecular Structure; Receptors, CXCR4; Small Molecule Libraries; Structure-Activity Relationship	2016
The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil). Biochemical pharmacology, 2009, Jun-01, Volume: 77, Issue:11 Topics: Amino Acid Sequence; Anti-HIV Agents; Benzylamines; Cyclams; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Heterocyclic Compounds; HIV; Humans; Lymphoma, Non-Hodgkin; Molecular Sequence Data; Multiple Myeloma; Protein Conformation; Receptors, CXCR4; Virus Internalization	2009
HIV fusion and its inhibition. Antiviral research, 2001, Volume: 50, Issue:2 Topics: Anti-HIV Agents; Benzylamines; CD4 Immunoadhesins; Cyclams; Enfuvirtide; Heterocyclic Compounds; HIV; HIV Envelope Protein gp41; HIV Infections; Humans; Membrane Fusion; Peptide Fragments; Receptors, HIV	2001

Other Studies

11 other study(ies) available for plerixafor and HIV

Article	Year
"Viologen" dendrimers as antiviral agents: the effect of charge number and distance. Journal of medicinal chemistry, 2010, May-13, Volume: 53, Issue:9 Topics: Anti-HIV Agents; Antiviral Agents; Cell Line; Dendrimers; HIV; Humans; Static Electricity; Structure-Activity Relationship; Viologens	2010
Synthesis, gp120 binding and anti-HIV activity of fatty acid esters of 1,1-linked disaccharides. Bioorganic & medicinal chemistry, 2011, Aug-15, Volume: 19, Issue:16 Topics: Antiviral Agents; Cell Line; Disaccharides; Drug Evaluation, Preclinical; Esters; Fatty Acids; Galactosylceramides; Glycolipids; HIV; HIV Envelope Protein gp120; HIV Infections; Humans; Micelles; Peptides; Protein Binding; Receptors, CXCR4; Structure-Activity Relationship; Surface Properties	2011
Exploratory studies on CA-15L, an anti-HIV active HIV-1 capsid fragment. Bioorganic & medicinal chemistry, 2020, 06-01, Volume: 28, Issue:11 Topics: Anti-HIV Agents; Capsid Proteins; Dose-Response Relationship, Drug; HIV; Humans; Microbial Sensitivity Tests; Molecular Structure; Peptide Fragments; Structure-Activity Relationship	2020
Novel monocyclam derivatives as HIV entry inhibitors: Design, synthesis, anti-HIV evaluation, and their interaction with the CXCR4 co-receptor. ChemMedChem, 2010, Aug-02, Volume: 5, Issue:8 Topics: Benzylamines; Cell Line; Cyclams; Drug Design; Heterocyclic Compounds; HIV; HIV Fusion Inhibitors; Humans; Molecular Dynamics Simulation; Protein Binding; Receptors, CXCR4	2010
R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms. Proceedings of the National Academy of Sciences of the United States of America, 2003, Jul-08, Volume: 100, Issue:14 Topics: Antibodies, Monoclonal; Benzylamines; CCR5 Receptor Antagonists; CD4 Antigens; CD4-Positive T-Lymphocytes; Cell Adhesion Molecules; Chemokine CCL5; Cyclams; Dendritic Cells; Endocytosis; Epithelial Cells; Female; Genetic Predisposition to Disease; Genotype; Heterocyclic Compounds; HIV; HIV Infections; Humans; Langerhans Cells; Lectins, C-Type; Male; Open Reading Frames; Polymorphism, Genetic; Receptors, CCR5; Receptors, Cell Surface; Receptors, CXCR4; Sequence Deletion; Virus Replication	2003
Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science (New York, N.Y.), 2004, Feb-20, Volume: 303, Issue:5661 Topics: Amino Acid Sequence; Animals; Benzylamines; Cats; CD4-Positive T-Lymphocytes; Cell Line; Cell Line, Tumor; Cyclams; DNA, Complementary; Gene Library; HeLa Cells; Heterocyclic Compounds; HIV; Humans; Immunodeficiency Virus, Feline; Mice; Molecular Sequence Data; NIH 3T3 Cells; Receptors, CXCR4; Receptors, OX40; Receptors, Tumor Necrosis Factor; Receptors, Virus; Species Specificity; Transduction, Genetic; Transfection	2004
Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins. Journal of virology, 2004, Volume: 78, Issue:19 Topics: Amino Acid Substitution; Anti-HIV Agents; Bacterial Proteins; Benzylamines; Caffeic Acids; Carrier Proteins; Cell Line; Coculture Techniques; Cyclams; Dextran Sulfate; Drug Resistance, Viral; Enfuvirtide; Giant Cells; Glycosylation; Heterocyclic Compounds; HIV; HIV Envelope Protein gp120; HIV Envelope Protein gp41; Liliaceae; Microbial Sensitivity Tests; Models, Molecular; Mutation, Missense; Peptide Fragments; Plant Lectins; Receptors, HIV; Succinates; Virus Replication	2004
Anti-HIV activity and resistance profile of the CXC chemokine receptor 4 antagonist POL3026. Molecular pharmacology, 2008, Volume: 73, Issue:4 Topics: Anti-HIV Agents; Antibodies, Monoclonal; Benzylamines; Calcium Signaling; Cell Death; Cell Line; Chemokine CXCL12; Chemotaxis; Cyclams; Drug Resistance, Viral; Heterocyclic Compounds; HIV; Humans; Leukocytes, Mononuclear; Lymphoid Tissue; Macrophages; Peptides, Cyclic; Receptors, CXCR4; Time Factors; Viral Envelope Proteins; Virus Replication	2008
Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4. Antiviral research, 1997, Volume: 35, Issue:3 Topics: Anti-HIV Agents; Benzylamines; Cell Line; Cells, Cultured; Cyclams; GTP-Binding Proteins; Heterocyclic Compounds; HIV; Humans; Membrane Proteins; Receptors, CXCR4; Receptors, HIV; Simian Immunodeficiency Virus; Virus Replication	1997
Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. The Journal of experimental medicine, 1997, Oct-20, Volume: 186, Issue:8 Topics: Anti-HIV Agents; Antibody Specificity; Benzylamines; Binding Sites, Antibody; Binding, Competitive; Calcium; Cell Line; Chemokine CXCL12; Chemokines, CXC; Chemotaxis, Leukocyte; Cyclams; Cytokines; Dose-Response Relationship, Drug; Heterocyclic Compounds; HIV; HIV-2; Humans; Receptors, CXCR4; T-Lymphocytes	1997
Promising anti-HIV therapeutic strategy with a small molecule CXCR4 antagonist. Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie, 1999, Volume: 61, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Benzylamines; Cyclams; Heterocyclic Compounds; HIV; HIV Infections; Humans; Receptors, CXCR4; T-Lymphocytes	1999